Erschienen in:
27.02.2020 | Breast Oncology
Response to: “Letter to the Editor: Is Low-Volume Disease in the Sentinel Node After Neoadjuvant Chemotherapy an Indication for Axillary Dissection? Miscalculation of Sensitivity and False Negative Rate”
verfasst von:
Tracy-Ann Moo, MD, Monica Morrow, MD
Erschienen in:
Annals of Surgical Oncology
|
Sonderheft 3/2020
Einloggen, um Zugang zu erhalten
Excerpt
We appreciate the time and effort Drs. Smiley and Castaldi have put into analysis of the results reported in our article entitled Is Low-Volume Disease in the Sentinel Node After Neoadjuvant Chemotherapy an Indication for Axillary Dissection? Upon review with our statistician, we agree there was an error in the calculation of the false-negative rate and sensitivity for the intraoperative frozen section procedure. As pointed out, the correct false-negative rate for frozen section is 15.4% and the correct sensitivity is 84.6%, instead of the reported 6.2% and 93.8%, respectively. We have submitted a correction to Annals of Surgical Oncology for publication. …